N-叔-丁基-1,4-丁烷二胺 | 13366-43-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: N-叔-丁基-1,4-丁烷二胺
• 中文别名: N-叔-丁基丁烷-1,4-二胺
• 英文名称: N-tert-Butyl-1,4-butandiamin
• 英文别名: Dibutadiamine；N'-tert-butylbutane-1,4-diamine
• CAS: 13366-43-3
• 化学式: C₈H₂₀N₂
• 分子量: 144.26
• InChiKey: JAUBXQBMUWRRNS-UHFFFAOYSA-N

物化性质

• 沸点：
  195.9±8.0 °C(Predicted)
• 密度：
  0.833±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  10
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  38
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 海关编码：
  2921290000

反应信息

• 作为反应物：
  描述：

  6,9-二氯-2-甲氧基吖啶 、 N-叔-丁基-1,4-丁烷二胺 生成 N¹-tert-butyl-N⁴-(6-chloro-2-methoxyacridin-9-yl)butane-1,4-diamine
  参考文献：
  名称：

  Autophagy Inhibitors

  摘要：

  本发明涉及公式III和V的化合物，这些化合物可用作药物制剂，特别是作为自噬抑制剂。

  公开号：

  US20140148451A1

文献信息

• COMPOUNDS FOR TREATING NEUROPSYCHIATRIC CONDITIONS
  申请人：Campbell David

  公开号：US20120046283A1

  公开（公告）日：2012-02-23

  Provided herein are PAK inhibitors and methods of utilizing PAK inhibitors for the treatment of neuropsychiatric conditions.

  本文提供了PAK抑制剂及其在治疗神经精神疾病方面的应用方法。
• Autophagy inhibitors
  申请人：MacKeigan Jeffrey Paul

  公开号：US09221760B2

  公开（公告）日：2015-12-29

  The present invention relates to compounds of formulas III and V that are useful as pharmaceutical agents, particularly as autophagy inhibitors.

  本发明涉及公式III和V的化合物，其作为药物剂量特别是自噬抑制剂具有用途。
• MODIFIED BLOCK COPOLYMER, METHOD FOR PRODUCING MODIFIED BLOCK COPOLYMER, AND RESIN COMPOSITION
  申请人：Asahi Kasei Kabushiki Kaisha

  公开号：EP3623398A1

  公开（公告）日：2020-03-18

  A modified block copolymer according to the present invention is a modified block copolymer comprising a polymer block comprising a vinyl aromatic compound as a main constituent (A), a polymer block comprising a conjugate diene compound as a main constituent (B), and an atomic group having NHx (x = 0 to 2) (C). In the modified block copolymer, the polymer block comprising a conjugate diene compound as a main constituent (B) is a hydrogenated product, the atomic group having NHx (x = 0 to 2) (C) is contained in a side chain, and a compound forming the atomic group having NHx (x = 0 to 2) (C) satisfies the following condition: Condition: when the compound forming the atomic group having NHx (x = 0 to 2) (C) is reacted with a maleic anhydride-modified group in a maleic anhydride-modified block copolymer, a MFR value at 230°C under a load of 2.16 kg of the modified block copolymer after the reaction is 0.1 times or more a MFR value at 230°C under a load of 2.16 kg of the maleic anhydride-modified block copolymer before the reaction.

  根据本发明，改性嵌段共聚物是一种改性嵌段共聚物，包括以乙烯基芳香族化合物为主要成分的聚合物嵌段（A）、以共轭二烯化合物为主要成分的聚合物嵌段（B）和具有 NHx（x = 0 至 2）的原子团（C）。在改性嵌段聚合物中，由共轭二烯化合物作为主要成分（B）的聚合物嵌段是氢化产物，具有 NHx（x = 0 至 2）（C）的原子团包含在侧链中，形成具有 NHx（x = 0 至 2）（C）的原子团的化合物满足以下条件： 条件：当形成具有 NHx（x = 0 至 2）(C)的原子团的化合物与马来酸酐改性嵌段共聚物中的马来酸酐改性基团反应时，反应后在 230℃、负载 2.16 千克改性嵌段共聚物时的 MFR 值是反应前在 230℃、负载 2.16 千克马来酸酐改性嵌段共聚物时的 MFR 值的 0.1 倍或以上。
• Chlorine-resistant polyethylene compound and articles made therefrom
  申请人：Fina Technology, Inc.

  公开号：US10584823B2

  公开（公告）日：2020-03-10

  A method includes transporting water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through a pipe. The method includes forming a polyethylene resin using a catalyst, mixing the polyethylene resin with an antioxidant, wherein the antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene to form a resin/antioxidant mixture, extruding pipe from the resin/antioxidant mixture, and flowing water containing chlorine dioxide, chlorine, chloramines, or hypochlorites through the pipe. An extruded article is adapted for use in containment and/or transport of water that contains chlorine dioxide, chlorine, chloramines, or hypochlorites. The extruded article includes a polyethylene resin and an antioxidant. The antioxidant is a thioester, a hindered amine light stabilizer or 1,3,5-trimethyl-2,4,6-tris (3,5-di-tert-butyl-4-hydroxybenzyl) benzene.

  一种方法包括通过管道输送含有二氧化氯、氯、氯胺或次氯酸盐的水。该方法包括使用催化剂形成聚乙烯树脂，将聚乙烯树脂与抗氧化剂混合，其中抗氧化剂为硫酯、受阻胺光稳定剂或 1，3，5-三甲基-2，4，6-三（3、5-二叔丁基-4-羟基苄基）苯形成树脂/抗氧化剂混合物，用树脂/抗氧化剂混合物挤出管材，并使含有二氧化氯、氯、氯胺或次氯酸盐的水流过管材。挤压制品适用于封闭和/或运输含有二氧化氯、氯、氯胺或次氯酸盐的水。挤压制品包括聚乙烯树脂和抗氧化剂。抗氧化剂是硫酯、受阻胺光稳定剂或 1,3,5-三甲基-2,4,6-三（3,5-二叔丁基-4-羟基苄基）苯。
• Protein-polymer-drug conjugates
  申请人：Mersana Therapeutics, Inc.

  公开号：US10603386B2

  公开（公告）日：2020-03-31

  A drug conjugate is provided herein. The conjugate comprises a protein based recognition-molecule (PBRM) and a polymeric carrier substituted with one or more -LD-D, the protein based recognition-molecule being connected to the polymeric carrier by LP. Each occurrence of D is independently a therapeutic agent having a molecular weight≤5 kDa. LD and LP are linkers connecting the therapeutic agent and PBRM to the polymeric carrier respectively. Also disclosed are polymeric scaffolds useful for conjugating with a PBRM to form a polymer-drug-PBRM conjugate described herein, compositions comprising the conjugates, methods of their preparation, and methods of treating various disorders with the conjugates or their compositions.

  本文提供了一种药物共轭物。该共轭物包括一个基于蛋白质的识别分子（PBRM）和一个或多个-LD-D 取代的聚合物载体，基于蛋白质的识别分子通过 LP 与聚合物载体连接。每一个 D 都是分子量小于 5 kDa 的治疗剂。LD 和 LP 分别是连接治疗剂和 PBRM 与聚合物载体的连接体。还公开了用于与 PBRM 共轭以形成本文所述聚合物-药物-PBRM 共轭物的聚合物支架、包含共轭物的组合物、其制备方法以及用共轭物或其组合物治疗各种疾病的方法。